Oncopro Focus Fusion Panel for Solid Tumors Test sale cost 8190 AED
Oncomine Comprehensive Myeloid Panel Test sale cost 6400 AED Oncomine Comprehensive Myeloid Panel Test Cost 10,000 د.إ Original price was: 10,000 د.إ.6,400 د.إCurrent price is: 6,400 د.إ.
Cancer 50 Gene Panel NGS Test sale cost 6000 AED Cancer 50 Gene Panel NGS Test Cost 8,000 د.إ Original price was: 8,000 د.إ.6,000 د.إCurrent price is: 6,000 د.إ.
Sale!

Oncopro Focus Fusion Panel for Solid Tumors Test Cost

Original price was: 9,100 د.إ.Current price is: 8,190 د.إ.

-10%

The “Oncopro Focus Fusion Panel for Solid Tumors Test” is an advanced diagnostic tool designed to provide comprehensive genetic insights into solid tumors. This test, conducted at DNA Labs UAE, is aimed at identifying specific gene fusions and alterations that are critical in the development, progression, and treatment response of various solid tumors. With a cost of 8190 AED, the test utilizes cutting-edge sequencing technologies to analyze a panel of genes associated with solid tumors, offering precise and personalized information that can guide targeted therapy decisions. By pinpointing the genetic underpinnings of a patient’s tumor, the Oncopro Focus Fusion Panel enables healthcare providers to tailor treatment strategies more effectively, potentially improving patient outcomes. This test represents a significant step forward in the field of oncology, offering hope for more effective and individualized cancer care.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ONCOPRO FOCUS FUSION PANEL FOR SOLID TUMORS Test

Test Cost: AED 8190.0

Test Components: AKT1, ALK, AR, BRAF, CDK4, CTNNB1, DDR2, EGFR, ERBB2, ERBB3, ERBB4, ESR1, FGFR2, FGFR3, GNA11, GNAQ, HRAS, IDH1, IDH2, JAK1, JAK2, JAK3, KIT, KRAS, MAP2K1, MAP2K2, MET, MTOR, NRAS, PDGFRA, PIK3CA, RAF1, RET, ROS1, SMO, CCND1, CDK6, FGFR1, FGFR4, MYC, MYCN, ABL1, AKT3, AXL, ERG, ETV1, ETV4, ETV5, NTRK1, NTRK2, NTRK3, PPARG

Price: AED 8190.0

Sample Condition: Submit formalin fixed paraffin embedded (FFPE) tissue block. Ship at room temperature. Block should have at least 10% tumor tissue.

Report Delivery: Sample Mon by 11 am; Report 15 Working days

Method: Next Generation Sequencing

Test Type: Cancer

Doctor: Oncologist

Test Department: MOLECULAR DIAGNOSTICS

Pre Test Information: Block should have at least 10% tumor tissue.

Test Details

The OncoPro Focus Fusion Panel for Solid Tumors is a genetic test that analyzes a patient’s tumor for specific genetic mutations and fusions that may be driving the growth of the cancer. The test uses next-generation sequencing technology to detect alterations in 52 genes that are commonly implicated in solid tumor cancers, including lung, breast, colon, and prostate cancers. The panel also includes fusion detection for 23 genes to identify gene fusions that may be driving tumor growth. The results of the test can help guide treatment decisions by identifying potential targets for personalized therapies or clinical trials.

Test Name ONCOPRO FOCUS FUSION PANEL FOR SOLID TUMORS Test
Components AKT1, ALK, AR, BRAF, CDK4, CTNNB1, DDR2, EGFR, ERBB2, ERBB3, ERBB4, ESR1, FGFR2, FGFR3, GNA11, GNAQ, HRAS, IDH1, IDH2, JAK1, JAK2, JAK3, KIT, KRAS, MAP2K1, MAP2K2, MET, MTOR, NRAS, PDGFRA, PIK3CA, RAF1, RET, ROS1, SMO, CCND1, CDK6, FGFR1, FGFR4, MYC, MYCN, ABL1, AKT3, AXL, ERG, ETV1, ETV4, ETV5, NTRK1, NTRK2, NTRK3, PPARG
Price 8190.0 AED
Sample Condition Submit formalin fixed paraffin embedded (FFPE) tissue block.Ship at room temperature. Block should have atleast 10% tumor tissue.
Report Delivery Sample Mon by 11 am; Report 15 Working days
Method Next Generation Sequencing
Test type Cancer
Doctor Oncologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information Block should have atleast 10% tumor tissue.
Test Details

The OncoPro Focus Fusion Panel for Solid Tumors is a genetic test that analyzes a patient’s tumor for specific genetic mutations and fusions that may be driving the growth of the cancer. The test uses next-generation sequencing technology to detect alterations in 52 genes that are commonly implicated in solid tumor cancers, including lung, breast, colon, and prostate cancers. The panel also includes fusion detection for 23 genes to identify gene fusions that may be driving tumor growth. The results of the test can help guide treatment decisions by identifying potential targets for personalized therapies or clinical trials.

SKU: TEST-760 Category:

Related products